Literature DB >> 11261812

Immediate causes of death of demented and non-demented elderly.

S Kammoun1, G Gold, C Bouras, P Giannakopoulos, W McGee, F Herrmann, J P Michel.   

Abstract

OBJECTIVE: To investigate the immediate causes of death, in autopsied demented and non-demented elderly.
DESIGN: Retrospective clinicopathologic correlations.
SETTING: Acute and intermediate care geriatric hospital. PARTICIPANTS: 342 hospitalized demented and non-demented elderly (mean age 84.94 +/- 6.9 years) who underwent consecutive postmortem examinations: 120 demented patients with either vascular dementia (VaD, n = 34), mixed dementia (MD, n = 65) or Alzheimer's disease (AD, n=21) neuropathologically confirmed and 222 nondemented elderly.
RESULTS: Primary causes of death were similar in both demented and non-demented patients; the commonest were cardiovascular disease and bronchopneumonia. Cardiac causes of death and especially cardiac failure were more frequent in VaD than in AD or MD (respectively P = 0.027 and 0.005). Dementia was an underlying but never a primary cause of death.
CONCLUSIONS: Immediate causes of death are similar in elderly demented and non-demented patients.

Entities:  

Mesh:

Year:  2000        PMID: 11261812     DOI: 10.1034/j.1600-0404.2000.00314.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  24 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

Review 2.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

3.  Thromboprophylaxis with the low-molecular-weight heparin bemiparin sodium in elderly medical patients in usual clinical practice: the ANCIANOS study.

Authors:  Leocadio Rodríguez-Mañas; Ricardo Gómez-Huelgas; Fernando Veiga-Fernández; Gema Monteagudo Ruiz; Javier Martínez González
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID).

Authors:  Tiffany L Sudduth; Erica M Weekman; Brittani R Price; Jennifer L Gooch; Abigail Woolums; Christopher M Norris; Donna M Wilcock
Journal:  Neuroscience       Date:  2016-11-25       Impact factor: 3.590

Review 5.  An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia.

Authors:  Brittani R Price; Christopher M Norris; Pradoldej Sompol; Donna M Wilcock
Journal:  J Neurochem       Date:  2018-01-22       Impact factor: 5.372

Review 6.  Barriers to excellent end-of-life care for patients with dementia.

Authors:  Greg A Sachs; Joseph W Shega; Deon Cox-Hayley
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

7.  Neuroinflammatory phenotype in early Alzheimer's disease.

Authors:  Tiffany L Sudduth; Frederick A Schmitt; Peter T Nelson; Donna M Wilcock
Journal:  Neurobiol Aging       Date:  2012-10-09       Impact factor: 4.673

8.  Bee Venom Ameliorates Cognitive Dysfunction Caused by Neuroinflammation in an Animal Model of Vascular Dementia.

Authors:  Mudan Cai; Jun Hwan Lee; Eun Jin Yang
Journal:  Mol Neurobiol       Date:  2016-09-29       Impact factor: 5.590

9.  Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.

Authors:  Tiffany L Sudduth; David K Powell; Charles D Smith; Abigail Greenstein; Donna M Wilcock
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-30       Impact factor: 6.200

Review 10.  Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

Authors:  Alex M Helman; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.